A recent study conducted at UKE Hamburg compared manual and software-assisted assessments of computed tomography (CT) scans according to iRECIST (immune Response Evaluation Criteria in Solid Tumors) in oncological patients undergoing immune-based treatment. Utilizing mint Lesion™ for software-assisted assessment, the study found that software-assisted assessments resulted in shorter reading times, lower error rates, and higher inter-reader agreement compared to manual assessments. The researchers thus concluded that software-assisted iRECIST assessments are preferable over manual approaches for optimal oncological response evaluation.
Software-Assisted CT Assessment Outperforms Manual Methods in Oncology Study
Related Resources
Related Resources
ESOI-EORTC Workshop: Hands-On Training in Assessing Tumor Response to Treatment
The ESOI-EORTC workshop, hosted by the European Society of Oncological Imaging (ESOI) and the European Organization for Research and Treatment of…
Systems on FHIR: Driving Healthcare Innovation Through Interoperability
Interoperability is revolutionizing healthcare by enabling the seamless exchange of patient data across systems. This efficient data flow is critical…
Human-AI Collaboration in Prostate Cancer Diagnosis
As prostate cancer diagnosis becomes increasingly complex, the collaboration between human expertise and artificial intelligence (AI) is emerging as a…